245 related articles for article (PubMed ID: 9389993)
1. Is growth hormone bad for your heart? Cardiovascular impact of GH deficiency and of acromegaly.
Lombardi G; Colao A; Marzullo P; Ferone D; Longobardi S; Esposito V; Merola B
J Endocrinol; 1997 Oct; 155 Suppl 1():S33-7; discussion S39. PubMed ID: 9389993
[TBL] [Abstract][Full Text] [Related]
2. The GH-IGF-I axis and the cardiovascular system: clinical implications.
Colao A
Clin Endocrinol (Oxf); 2008 Sep; 69(3):347-58. PubMed ID: 18462260
[TBL] [Abstract][Full Text] [Related]
3. Effect of growth hormone on cardiac function.
Lombardi G; Colao A; Ferone D; Marzullo P; Orio F; Longobardi S; Merola B
Horm Res; 1997; 48 Suppl 4():38-42. PubMed ID: 9350445
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone, acromegaly, and heart failure: an intricate triangulation.
Saccà L; Napoli R; Cittadini A
Clin Endocrinol (Oxf); 2003 Dec; 59(6):660-71. PubMed ID: 14974906
[TBL] [Abstract][Full Text] [Related]
5. Role of growth hormone in chronic heart failure: therapeutic implications.
Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A
Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515
[TBL] [Abstract][Full Text] [Related]
6. Cardiological aspects of growth hormone and insulin-like growth factor-I.
Lombardi G; Colao A; Cuocolo A; Longobardi S; Di Somma C; Orio F; Merola B; Nicolai E; Salvatore M
J Pediatr Endocrinol Metab; 1997; 10(6):553-60. PubMed ID: 9467124
[TBL] [Abstract][Full Text] [Related]
7. Improvement of intrinsic myocardial contractility and cardiac fibrosis degree in acromegalic patients treated with somatostatin analogues: a prospective study.
Bogazzi F; Di Bello V; Palagi C; Donne MG; Di Cori A; Gavioli S; Talini E; Cosci C; Sardella C; Brogioni S; Mariani M; Martino E
Clin Endocrinol (Oxf); 2005 May; 62(5):590-6. PubMed ID: 15853830
[TBL] [Abstract][Full Text] [Related]
8. [Heart disease in acromegaly. Study of 27 patients].
Marín F; Picó AM; Martínez JG; Domínguez JR; Alfayete R; Sogorb F
Med Clin (Barc); 1996 Sep; 107(9):326-30. PubMed ID: 8984234
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular complications in acromegaly.
Vitale G; Pivonello R; Lombardi G; Colao A
Minerva Endocrinol; 2004 Sep; 29(3):77-88. PubMed ID: 15282442
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone and the heart.
Colao A; Marzullo P; Di Somma C; Lombardi G
Clin Endocrinol (Oxf); 2001 Feb; 54(2):137-54. PubMed ID: 11207626
[TBL] [Abstract][Full Text] [Related]
11. The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency.
Minczykowski A; Gryczynska M; Ziemnicka K; Czepczynski R; Sowinski J; Wysocki H
Growth Horm IGF Res; 2005 Apr; 15(2):156-64. PubMed ID: 15809020
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and metabolic effects of recombinant human growth hormone in cardiac insufficiency].
Modlińska A; Babińska A; Faran G; Sworczak K
Przegl Lek; 2003; 60(5):349-52. PubMed ID: 14593678
[TBL] [Abstract][Full Text] [Related]
13. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment.
Colao A; Terzolo M; Bondanelli M; Galderisi M; Vitale G; Reimondo G; Ambrosio MR; Pivonello R; Lombardi G; Angeli A; degli Uberti EC
Clin Endocrinol (Oxf); 2008 Oct; 69(4):613-20. PubMed ID: 18410555
[TBL] [Abstract][Full Text] [Related]
14. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
15. [Therapy of dilated cardiomyopathy with recombinant human growth hormone].
Osterziel KJ; Markus U; Willenbrock R; Strohm O; Dietz R
Z Kardiol; 1997 Oct; 86(10):803-11. PubMed ID: 9454447
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone and cardiac function.
Lombardi G; Di Somma C; Marzullo P; Cerbone G; Colao A
Ann Endocrinol (Paris); 2000 Feb; 61(1):16-21. PubMed ID: 10790587
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone and the heart.
Saccà L; Cittadini A; Fazio S
Endocr Rev; 1994 Oct; 15(5):555-73. PubMed ID: 7843068
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular consequences of early-onset growth hormone excess.
Colao A; Spinelli L; Cuocolo A; Spiezia S; Pivonello R; di Somma C; Bonaduce D; Salvatore M; Lombardi G
J Clin Endocrinol Metab; 2002 Jul; 87(7):3097-104. PubMed ID: 12107207
[TBL] [Abstract][Full Text] [Related]
19. Effects of a 7-day continuous infusion of octreotide on circulating levels of growth factors and binding proteins in growth hormone (GH)-treated GH-deficient patients.
Laursen T; Møller J; Fisker S; Jorgensen JO; Christiansen JS
Growth Horm IGF Res; 1999 Dec; 9(6):451-7. PubMed ID: 10629166
[TBL] [Abstract][Full Text] [Related]
20. Cardiac IGF-I manipulation by growth hormone following myocardial infarction.
Matthews KG; Devlin GP; Stuart SP; Conaglen JV; Bass JJ
Growth Horm IGF Res; 2004 Jun; 14(3):251-60. PubMed ID: 15125887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
